Renal handling of carnitine in secondary Carnitine deficiency disorders

Charles A. Stanley, Gerard T. Berry, Michael J. Bennett, Steven M. Willi, William R. Treem, Daniel E. Hale

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Reduced plasma and tissue concentrations of carnitine, a cofactor required for fatty acid oxidation, are present in patients with inherited disorders of mitochondrial acyl-CoA oxidation that are associated with accumulations of acylcarnitines. To determine whether the secondary carnitine deficiency in these patients is due to excessive urinary loss of acylcarnitines, the development of carnitine deficiency was examined in patients with four different acyl-CoA oxidation disorders, including medium-chain and long-chain fatty acyl-CoA dehydrogenase deficiencies, isovaleric acidemia, and propionic acidemia. After a 3-mo period of treatment with oral carnitine to raise plasma total carnitine concentrations to or above normal, patients were started on a carnitine-free diet and the changes in plasma total and free carnitine levels and urinary total and free carnitine excretion were followed for 5 d. Patients with all four disorders showed a return of plasma carnitine levels and urinary carnitine excretion to baseline within 2 to 4 d. The rapidity of these changes could not be explained solely by excessive acylcarnitine wasting. Continued excretion of free carnitine in all patients indicated the additional presence of an impairment in renal transport of free carnitine. Consistent with this interpretation, estimates of renal thresholds for free carnitine gave values that were less than that for a control child in all four disorders and ranged as low as one half those reported in normal individuals. These results suggest that secondary carnitine deficiency in the acyl-CoA oxidation disorders is due to indirect as well as direct effects of accumulated acylcarnitines. Lowered renal free carnitine thresholds in these patients may reflect inhibition of free carnitine transport in the kidney by acylcarnitines.

Original languageEnglish (US)
Pages (from-to)89-97
Number of pages9
JournalPediatric Research
Volume34
Issue number1
StatePublished - Jul 1993

Fingerprint

Carnitine
Kidney
Acyl Coenzyme A
Propionic Acidemia
Acyl-CoA Dehydrogenase
Mitochondrial Diseases

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Stanley, C. A., Berry, G. T., Bennett, M. J., Willi, S. M., Treem, W. R., & Hale, D. E. (1993). Renal handling of carnitine in secondary Carnitine deficiency disorders. Pediatric Research, 34(1), 89-97.
Stanley, Charles A. ; Berry, Gerard T. ; Bennett, Michael J. ; Willi, Steven M. ; Treem, William R. ; Hale, Daniel E. / Renal handling of carnitine in secondary Carnitine deficiency disorders. In: Pediatric Research. 1993 ; Vol. 34, No. 1. pp. 89-97.
@article{a6fdd15e7a844f0dac4f0669b54501eb,
title = "Renal handling of carnitine in secondary Carnitine deficiency disorders",
abstract = "Reduced plasma and tissue concentrations of carnitine, a cofactor required for fatty acid oxidation, are present in patients with inherited disorders of mitochondrial acyl-CoA oxidation that are associated with accumulations of acylcarnitines. To determine whether the secondary carnitine deficiency in these patients is due to excessive urinary loss of acylcarnitines, the development of carnitine deficiency was examined in patients with four different acyl-CoA oxidation disorders, including medium-chain and long-chain fatty acyl-CoA dehydrogenase deficiencies, isovaleric acidemia, and propionic acidemia. After a 3-mo period of treatment with oral carnitine to raise plasma total carnitine concentrations to or above normal, patients were started on a carnitine-free diet and the changes in plasma total and free carnitine levels and urinary total and free carnitine excretion were followed for 5 d. Patients with all four disorders showed a return of plasma carnitine levels and urinary carnitine excretion to baseline within 2 to 4 d. The rapidity of these changes could not be explained solely by excessive acylcarnitine wasting. Continued excretion of free carnitine in all patients indicated the additional presence of an impairment in renal transport of free carnitine. Consistent with this interpretation, estimates of renal thresholds for free carnitine gave values that were less than that for a control child in all four disorders and ranged as low as one half those reported in normal individuals. These results suggest that secondary carnitine deficiency in the acyl-CoA oxidation disorders is due to indirect as well as direct effects of accumulated acylcarnitines. Lowered renal free carnitine thresholds in these patients may reflect inhibition of free carnitine transport in the kidney by acylcarnitines.",
author = "Stanley, {Charles A.} and Berry, {Gerard T.} and Bennett, {Michael J.} and Willi, {Steven M.} and Treem, {William R.} and Hale, {Daniel E.}",
year = "1993",
month = "7",
language = "English (US)",
volume = "34",
pages = "89--97",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Stanley, CA, Berry, GT, Bennett, MJ, Willi, SM, Treem, WR & Hale, DE 1993, 'Renal handling of carnitine in secondary Carnitine deficiency disorders', Pediatric Research, vol. 34, no. 1, pp. 89-97.

Renal handling of carnitine in secondary Carnitine deficiency disorders. / Stanley, Charles A.; Berry, Gerard T.; Bennett, Michael J.; Willi, Steven M.; Treem, William R.; Hale, Daniel E.

In: Pediatric Research, Vol. 34, No. 1, 07.1993, p. 89-97.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Renal handling of carnitine in secondary Carnitine deficiency disorders

AU - Stanley, Charles A.

AU - Berry, Gerard T.

AU - Bennett, Michael J.

AU - Willi, Steven M.

AU - Treem, William R.

AU - Hale, Daniel E.

PY - 1993/7

Y1 - 1993/7

N2 - Reduced plasma and tissue concentrations of carnitine, a cofactor required for fatty acid oxidation, are present in patients with inherited disorders of mitochondrial acyl-CoA oxidation that are associated with accumulations of acylcarnitines. To determine whether the secondary carnitine deficiency in these patients is due to excessive urinary loss of acylcarnitines, the development of carnitine deficiency was examined in patients with four different acyl-CoA oxidation disorders, including medium-chain and long-chain fatty acyl-CoA dehydrogenase deficiencies, isovaleric acidemia, and propionic acidemia. After a 3-mo period of treatment with oral carnitine to raise plasma total carnitine concentrations to or above normal, patients were started on a carnitine-free diet and the changes in plasma total and free carnitine levels and urinary total and free carnitine excretion were followed for 5 d. Patients with all four disorders showed a return of plasma carnitine levels and urinary carnitine excretion to baseline within 2 to 4 d. The rapidity of these changes could not be explained solely by excessive acylcarnitine wasting. Continued excretion of free carnitine in all patients indicated the additional presence of an impairment in renal transport of free carnitine. Consistent with this interpretation, estimates of renal thresholds for free carnitine gave values that were less than that for a control child in all four disorders and ranged as low as one half those reported in normal individuals. These results suggest that secondary carnitine deficiency in the acyl-CoA oxidation disorders is due to indirect as well as direct effects of accumulated acylcarnitines. Lowered renal free carnitine thresholds in these patients may reflect inhibition of free carnitine transport in the kidney by acylcarnitines.

AB - Reduced plasma and tissue concentrations of carnitine, a cofactor required for fatty acid oxidation, are present in patients with inherited disorders of mitochondrial acyl-CoA oxidation that are associated with accumulations of acylcarnitines. To determine whether the secondary carnitine deficiency in these patients is due to excessive urinary loss of acylcarnitines, the development of carnitine deficiency was examined in patients with four different acyl-CoA oxidation disorders, including medium-chain and long-chain fatty acyl-CoA dehydrogenase deficiencies, isovaleric acidemia, and propionic acidemia. After a 3-mo period of treatment with oral carnitine to raise plasma total carnitine concentrations to or above normal, patients were started on a carnitine-free diet and the changes in plasma total and free carnitine levels and urinary total and free carnitine excretion were followed for 5 d. Patients with all four disorders showed a return of plasma carnitine levels and urinary carnitine excretion to baseline within 2 to 4 d. The rapidity of these changes could not be explained solely by excessive acylcarnitine wasting. Continued excretion of free carnitine in all patients indicated the additional presence of an impairment in renal transport of free carnitine. Consistent with this interpretation, estimates of renal thresholds for free carnitine gave values that were less than that for a control child in all four disorders and ranged as low as one half those reported in normal individuals. These results suggest that secondary carnitine deficiency in the acyl-CoA oxidation disorders is due to indirect as well as direct effects of accumulated acylcarnitines. Lowered renal free carnitine thresholds in these patients may reflect inhibition of free carnitine transport in the kidney by acylcarnitines.

UR - http://www.scopus.com/inward/record.url?scp=0027276043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027276043&partnerID=8YFLogxK

M3 - Article

C2 - 8356025

AN - SCOPUS:0027276043

VL - 34

SP - 89

EP - 97

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -

Stanley CA, Berry GT, Bennett MJ, Willi SM, Treem WR, Hale DE. Renal handling of carnitine in secondary Carnitine deficiency disorders. Pediatric Research. 1993 Jul;34(1):89-97.